In a landmark shift for the biopharmaceutical industry, the U.S. Food and Drug Administration (FDA) has unveiled...
Treatment Innovations
The marriage of artificial intelligence and pharmaceutical research has long been promised as a panacea for the...
In a landmark development for digital health, San Francisco-based Sirona Medical has successfully closed a $40 million...
In a significant move to modernize its approach to orphan drug development, the U.S. Food and Drug...
The intersection of artificial intelligence and pharmaceutical research has long been promised as a transformative frontier, a...
In a landmark move for the health-tech sector, California-based Sirona Medical has successfully closed a $40 million...
In a landmark shift toward modernizing the regulatory landscape for orphan drug development, the U.S. Food and...
The stock market’s relationship with artificial intelligence is currently defined by a sharp dichotomy. While Wall Street...
In a landmark move for the health-tech sector, California-based Sirona Medical has successfully closed a $40 million...
By [Your Name/Industry Correspondent] The American Association of Pharmaceutical Scientists (AAPS), a global non-profit organization representing more...
